The atherosclerotic cardiovascular disease market in the 7MM is expected to show positive growth during the forecast period (2025–2034), mainly attributed to the launch of upcoming therapies such as ...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced its new five-year strategy, "Alnylam ...

SpainSat NG II remains stable, intact, and in a highly eccentric orbit. Its current position ensures that it does not pose any risk or interference to existing or future space missions. The loss of ...